Lysine lactylation in the regulation of tumor biology

Trends Endocrinol Metab. 2024 Feb 22:S1043-2760(24)00025-0. doi: 10.1016/j.tem.2024.01.011. Online ahead of print.ABSTRACTLysine lactylation (Kla), a newly discovered post-translational modification (PTM) of lysine residues, is progressively revealing its crucial role in tumor biology. A growing body of evidence supports its capacity of transcriptional regulation through histone modification and modulation of non-histone protein function. It intricately participates in a myriad of events in the tumor microenvironment (TME) by orchestrating the transitions of immune states and augmenting tumor malignancy. Its preferential modification of metabolic proteins underscores its specific regulatory influence on metabolism. This review focuses on the effect and the probable mechanisms of Kla-mediated regulation of tumor metabolism, the upstream factors that determine Kla intensity, and its potential implications for the clinical diagnosis and treatment of tumors.PMID:38395657 | DOI:10.1016/j.tem.2024.01.011
Source: Trends in Endocrinology and Metabolism: TEM - Category: Endocrinology Authors: Source Type: research